Organogenesis Holdings Inc (ORGO)
2.905
+0.04
(+1.57%)
USD |
NASDAQ |
Apr 19, 16:00
2.905
0.00 (0.00%)
After-Hours: 18:50
Organogenesis Holdings Cash from Financing (TTM): -5.505M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -5.505M |
September 30, 2023 | -5.603M |
June 30, 2023 | -4.139M |
March 31, 2023 | -2.67M |
December 31, 2022 | -2.199M |
September 30, 2022 | -1.241M |
June 30, 2022 | 0.003M |
March 31, 2022 | -1.21M |
December 31, 2021 | -1.036M |
September 30, 2021 | 30.00M |
June 30, 2021 | 27.96M |
March 31, 2021 | 33.65M |
December 31, 2020 | 42.47M |
September 30, 2020 | 59.42M |
June 30, 2020 | 69.92M |
Date | Value |
---|---|
March 31, 2020 | 67.82M |
December 31, 2019 | 78.73M |
September 30, 2019 | 44.94M |
June 30, 2019 | 83.72M |
March 31, 2019 | 97.59M |
December 31, 2018 | 81.54M |
September 30, 2018 | 87.55M |
June 30, 2018 | 39.04M |
March 31, 2018 | 22.38M |
December 31, 2017 | 18.87M |
September 30, 2017 | 6.278M |
June 30, 2017 | 6.368M |
March 31, 2017 | 6.368M |
December 31, 2016 | 6.776M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-5.603M
Minimum
Sep 2023
83.72M
Maximum
Jun 2019
27.11M
Average
27.96M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Ampio Pharmaceuticals Inc | 0.00 |